Medimetriks Pharmaceuticals, Inc. Begins Operations; Bradley Pharmaceuticals (BDY) Founder and Senior Management Form Company Specializing in Dermatology and Podiatry Markets
5/13/2008 8:27:33 AM
More...
|
Nycomed Successfully Completed the Acquisition of Bradley Pharmaceuticals (BDY)
2/22/2008 6:29:54 AM
More...
|
Bradley Pharmaceuticals (BDY) Announces Filing of Definitive Proxy Statement for Special Meeting of Stockholders to Approve Merger With Nycomed
1/18/2008 7:26:08 AM
More...
|
BioSante Pharmaceuticals, Inc. (BPA) Receives Milestone Payment from Bradley Pharmaceuticals (BDY)
12/18/2007 2:20:30 PM
More...
|
Bradley Pharmaceuticals (BDY) Launches Veregen(TM) (sinecatechins) Ointment, 15%
12/14/2007 8:26:04 AM
More...
|
Bradley Pharmaceuticals (BDY) Launches ROSULA(R) CLK(TM)
11/26/2007 10:07:29 AM
More...
|
Bradley Pharmaceuticals (BDY) 2007 Third Quarter Results
11/9/2007 9:53:59 AM
More...
|
Bradley Pharmaceuticals (BDY) to be Bought by Nycomed for $20/Share
10/30/2007 6:41:54 AM
More...
|
Bradley Pharmaceuticals (BDY) to Feature Elestrin(TM) at North American Menopause Society Annual Meeting
9/28/2007 10:31:06 AM
More...
|
Bradley Pharmaceuticals (BDY) to Report Second Quarter 2007 Financial Results and Schedules Conference Call
7/31/2007 10:44:04 AM
More...
|
|